Double concentric autofluorescence ring in NR2E3-p.G56R-linked autosomal dominant retinitis pigmentosa

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 8, 2012, Pages 4754-4764

  Escher, Pascal ^a,b   Tran, Hoai V ^c   Vaclavik, Veronika ^c   Borruat, Francois X ^c   Schorderet, Daniel F ^a,b,d   Munier, Francis L ^c  

^a Institute for Research in Ophthalmology IRO   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c JULES GONIN EYE HOSPITAL   (Switzerland)

^d EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; NR2E3-P.G56R MUTANT PROTEIN; UNCLASSIFIED DRUG; NR2E3 PROTEIN, HUMAN; ORPHAN NUCLEAR RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOFLUORESCENCE; AUTOSOMAL DOMINANT RETINITIS PIGMENTOSA; BLINDNESS; CLINICAL ARTICLE; DISEASE COURSE; ELECTRORETINOGRAPHY; EYE PHOTOGRAPHY; FEMALE; FUNDUS AUTOFLUORESCENCE; GENE; HUMAN; MACULAR THICKNESS; MALE; MOLECULAR GENETICS; MUTATION; NEAR INFRARED AUTOFLUORESCENCE; NIGHT BLINDNESS; NR2E3 GENE; OPTICAL COHERENCE TOMOGRAPHY; PHOTORECEPTOR INNER SEGMENT; PHOTORECEPTOR OUTER SEGMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA DEGENERATION; RETINA DYSTROPHY; RETINA MACULOPATHY; RETINITIS PIGMENTOSA; SCOTOMA; VISUAL FIELD; CROSS-SECTIONAL STUDY; FLUORESCENCE ANGIOGRAPHY; GENETICS; MIDDLE AGED; MOLECULAR BIOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SWITZERLAND;

ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; MALE; MIDDLE AGED; MOLECULAR BIOLOGY; ORPHAN NUCLEAR RECEPTORS; RETINITIS PIGMENTOSA; SWITZERLAND; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL FIELDS;

EID: 84866785423     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-8693     Document Type: Article

References (42)

1. Kobayashi M, Takezawa S, Hara K, et al. Identification of a photoreceptor cell-specific nuclear receptor. Proc Natl Acad Sci USA. 1999;96:4814-4819.
2. Haider NB, Demarco P, Nystuen AM, et al. The transcription factor Nr2e3 functions in retinal progenitors to suppress cone cell generation. Vis Neurosci. 2006;23:917-929.
3. Cheng H, Khanna H, Oh EC, Hicks D, Mitton KP, Swaroop A. Photoreceptor-specific nuclear receptor NR2E3 functions as a transcriptional activator in rod photoreceptors. Hum Mol Genet. 2004;13:1563-1575.
4. Chen J, Rattner A, Nathans J. The rod photoreceptor-specific nuclear receptor Nr2e3 represses transcription of multiple cone-specific genes. J Neurosci. 2005;25:118-129.
5. Peng GH, Ahmad O, Ahmad F, Liu J, Chen S. The photoreceptor-specific nuclear receptor Nr2e3 interacts with Crx and exerts opposing effects on the transcription of rod versus cone genes. Hum Mol Genet. 2005;14:747-764.
6. Onishi A, Peng GH, Hsu C, Alexis U, Chen S, Blackshaw S. Pias3-dependent SUMOylation directs rod photoreceptor development. Neuron. 2009;61:234-246.
7. Jacobson SG, Sumaroka A, Aleman TS, et al. Nuclear receptor NR2E3 gene mutations distort human retinal laminar architecture and cause an unusual degeneration. Hum Mol Genet. 2004;13:1893-1902.
8. Corbo JC, Cepko CL. A hybrid photoreceptor expressing both rod and cone genes in a mouse model of enhanced S-cone syndrome. PLoS Genet. 2005;1:e11.
9. Schorderet DF, Escher P. NR2E3 mutations in enhanced S-cone sensitivity syndrome (ESCS), Goldmann-Favre syndrome (GFS), clumped pigmentary retinal degeneration (CPRD), and retinitis pigmentosa (RP). Hum Mutat. 2009;30:1475-1485.
10. Marmor MF, Jacobson SG, Foerster MH, Kellner U, Weleber RG. Diagnostic clinical findings of a new syndrome with night blindness, maculopathy, and enhanced S cone sensitivity. Am J Ophthalmol. 1990;110:124-134.
11. Haider NB, Jacobson SG, Cideciyan AV, et al. Mutation of a nuclear receptor gene, NR2E3, causes enhanced S cone syndrome, a disorder of retinal cell fate. Nat Genet. 2000;24: 127-131.
12. Gerber S, Rozet JM, Takezawa SI, et al. The photoreceptor cellspecific nuclear receptor gene (PNR) accounts for retinitis pigmentosa in the Crypto-Jews from Portugal (Marranos), survivors from the Spanish Inquisition. Hum Genet. 2000;107: 276-284.
13. Sharon D, Sandberg MA, Caruso RC, Berson EL, Dryja T. Shared mutations in NR2E3 in enhanced S-cone syndrome, Goldmann-Favre syndrome, and many cases of clumped pigmentary retinal degeneration. Arch Ophthalmol. 2003;121:1316-1323.
14. Audo I, Michaelides M, Robson AG, et al. Phenotypic variation in enhanced S-cone syndrome. Invest Ophthalmol Vis Sci. 2008;49:2082-2093.
15. Pachydaki SI, Klaver CC, Barbazetto IA, et al. Phenotypic features of patients with NR2E3 mutations. Arch Ophthalmol. 2009;127:71-75.
16. Jacobson SG, Marmor MF, Kemp CM, Knighton RW. SWS (blue) cone hypersensitivity in a newly identified retinal degeneration. Invest Ophthalmol Vis Sci. 1990;31:827-838.
17. Coppieters F, Leroy BP, Beysen D, et al. Recurrent mutation inthe first zinc finger of the orphan nuclear receptor NR2E3 causes autosomal dominant retinitis pigmentosa. Am J Hum Genet. 2007;81:147-157.
18. Gire AI, Sullivan LS, Bowne SJ, et al. The Gly56Arg mutation in NR2E3 accounts for 1-2% of autosomal dominant retinitis pigmentosa. Mol Vis. 2007;13:1970-1975.
19. Escher P, Gouras P, Roduit R, et al. Mutations in NR2E3 can cause dominant or recessive retinal degenerations in the same family. Hum Mutat. 2009;30:342-351.
20. Yang Y, Zhang X, Chen LJ, et al. Association of NR2E3 but not NRL mutations with retinitis pigmentosa in the Chinesepopulation. Invest Ophthalmol Vis Sci. 2010;51:2229-2235.
21. Audo I, Bujakowska KM, Leveillard T, et al. Development and application of a next-generation-sequencing (NGS) approach to detect known and novel gene defects underlying retinal diseases. Orphanet J Rare Dis. 2012;7:8.
22. Roduit R, Escher P, Schorderet DF. Mutations in the DNA-binding domain affect in vivo NR2E3 dimerization and interaction with CRX. PLoS One. 2009;4:e7379.
23. Freund CL, Gregory-Evans CY, Furukawa T, et al. Cone-rod dystrophy due to mutations in a novel photoreceptor-specific homeobox gene (CRX) essential for maintenance of the photoreceptor. Cell. 1997;91:543-553.
24. Freund CL, Wang QL, Chen S, et al. De novo mutations in the CRX homeobox gene associated with Leber congenital amaurosis. Nat Genet. 1998;18:311-312.
25. Delori FC, Dorey CK, Staurenghi G, Arend O, Goger DG, Weiter JJ. In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics. Invest Ophthalmol Vis Sci. 1995;36:718-729.
26. Keilhauer CN, Delori FC. Near-infrared autofluorescence imaging of the fundus: visualization of ocular melanin. Invest Ophthalmol Vis Sci. 2006;47:3556-3564.
27. Marmor MF, Fulton AB, Holder GE, et al. ISCEV Standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol. 2009;118:69-77.
28. Bouayed-Tiab L, Delarive T, Agosti C, Borruat F-X, Munier FL, Schorderet DF. A heterozygous mutation in the NR2E3 Gene is associated with an autosomal dominant Retinitis Pigmentosa. Abstract presented at: Annual Meeting of the Association for Research in Vision and Ophthalmology; May 2006; Fort Lauderdale, FL. Abstract 1033.
29. Vaclavik V, Gaillard MC, Tiab L, Schorderet DF, Munier FL. Variable phenotypic expressivity in a Swiss family with autosomal dominant retinitis pigmentosa due to a T494M mutation in the PRPF3 gene. Mol Vis. 2010;16:467-475.
30. Michaelides M, Gaillard MC, Escher P, et al. The PROM1 mutation p.R373C causes an autosomal dominant bull's eye maculopathy associated with rod, rod-cone and macular dystrophy. Invest Ophthalmol Vis Sci. 2010;51:4771-4780.
31. Kellner U, Kellner S, Weber BH, Fiebig B, Weinitz S, Ruether K. Lipofuscin and melanin-related fundus autofluorescence visualize different retinal pigment epithelial alterations in patients with retinitis pigmentosa. Eye. 2009;23:1349-1359.
32. Robson AG, El-Amir A, Bailey C, et al. Pattern ERG correlates of abnormal fundus autofluorescence in patients with retinitis pigmentosa and normal visual acuity. Invest Ophthalmol Vis Sci. 2003;44:3544-3550.
33. Robson AG, Saihan Z, Jenkins SA, et al. Functional characterisation and serial imaging of abnormal fundus autofluorescence in patients with retinitis pigmentosa and normal visual acuity. Br J Ophthalmol. 2006;90:472-479.
34. Lenassi E, Troeger E, Wilke R, Hawlina M. Correlation between macular morphology and sensitivity in patients with retinitis pigmentosa and hyperautofluorescent ring. Invest Ophthalmol Vis Sci. 2012;53:47-52.
35. Robson AG, Michaelides M, Saihan Z, et al. Functional characteristics of patients with retinal dystrophy that manifest abnormal parafoveal annuli of high density fundus autofluorescence; a review and update. Doc Ophthalmol. 2008;116: 79-89.
36. Robson AG, Tufail A, Fitzke F, et al. Serial imaging and structure-function correlates of high-density rings of fundus autofluorescence in retinitis pigmentosa. Retina. 2011;31: 1670-1679.
37. Murakami T, Akimoto M, Ooto S, et al. Association between abnormal autofluorescence and photoreceptor disorganization in retinitis pigmentosa. Am J Ophthalmol. 2008;145:687-694.
38. Wakabayashi T, Sawa M, Gomi F, Tsujikawa M. Correlation of fundus autofluorescence with photoreceptor morphology and functional changes in eyes with retinitis pigmentosa. Acta Ophthalmol. 2010;88:e177-e183.
39. Robson AG, Egan CA, Luong VA, Bird AC, Holder GE, Fitzke FW. Comparison of fundus autofluorescence with photopic and scotopic fine-matrix mapping in patients with retinitis pigmentosa and normal visual acuity. Invest Ophthalmol Vis Sci. 2004;45:4119-4125.
40. Popovic P, Jarc-Vidmar M, Hawlina M. Abnormal fundus autofluorescence in relation to retinal function in patients with retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol. 2005;243:1018-1027.
41. Bandah D, Merin S, Ashhab M, Banin E, Sharon D. The spectrum of retinal diseases caused by NR2E3 mutations in Israeli and Palestinian patients. Arch Ophthalmol. 2009;127: 297-302.
42. Wang NK, Fine H, Chang S, et al. Cellular origin of fundus autofluorescence in patients and mice with defective NR2E3 Gene. Br J Ophthalmol. 2009;93:1234-1240.